Work

Indacaterol/glycopyrronium (IND/GLY) reduces exacerbations compared with salmeterol/fluticasone (SFC) in various sub-groups from the FLAME study

Year: 2016

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2016.pa991

Authors: Jadwiga Wedzicha, Kenneth Chapman, Angel FowlerTaylor, Tim Ayers, Chau Thach, Petter Olsson, Robert Fogel, Francesco Patalano, Donald Banerji

Institutions: Imperial College London, University Health Network, University of Toronto, Novartis (Switzerland), Novartis (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2553178635

Cites:

Cited by:

Related to: 10